BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 25062951)

  • 1. Progression of coronary artery calcification seems to be inevitable, but predictable - results of the Heinz Nixdorf Recall (HNR) study.
    Erbel R; Lehmann N; Churzidse S; Rauwolf M; Mahabadi AA; Möhlenkamp S; Moebus S; Bauer M; Kälsch H; Budde T; Montag M; Schmermund A; Stang A; Führer-Sakel D; Weimar C; Roggenbuck U; Dragano N; Jöckel KH;
    Eur Heart J; 2014 Nov; 35(42):2960-71. PubMed ID: 25062951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic risk scores for coronary artery disease and its traditional risk factors: Their role in the progression of coronary artery calcification-Results of the Heinz Nixdorf Recall study.
    Pechlivanis S; Moebus S; Lehmann N; Erbel R; Mahabadi AA; Hoffmann P; Jöckel KH; Nöthen MM; Bachmann HS;
    PLoS One; 2020; 15(5):e0232735. PubMed ID: 32379805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Value of Progression of Coronary Artery Calcification for Risk Prediction of Coronary and Cardiovascular Events: Result of the HNR Study (Heinz Nixdorf Recall).
    Lehmann N; Erbel R; Mahabadi AA; Rauwolf M; Möhlenkamp S; Moebus S; Kälsch H; Budde T; Schmermund A; Stang A; Führer-Sakel D; Weimar C; Roggenbuck U; Dragano N; Jöckel KH;
    Circulation; 2018 Feb; 137(7):665-679. PubMed ID: 29142010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacogenetic association of diabetes-associated genetic risk score with rapid progression of coronary artery calcification following treatment with HMG-CoA-reductase inhibitors -results of the Heinz Nixdorf Recall Study.
    Pechlivanis S; Jung D; Moebus S; Lehmann N; Mahabadi AA; Hoffmann P; Erbel R; Nöthen MM; Bachmann HS
    Naunyn Schmiedebergs Arch Pharmacol; 2021 Aug; 394(8):1713-1725. PubMed ID: 34021798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of dietary patterns with five-year degree and progression of coronary artery calcification in the Heinz Nixdorf Recall study.
    Frölich S; Lehmann N; Weyers S; Wahl S; Dragano N; Budde T; Kälsch H; Mahabadi AA; Erbel R; Moebus S; Jöckel KH; Schmidt B;
    Nutr Metab Cardiovasc Dis; 2017 Nov; 27(11):999-1007. PubMed ID: 29074383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of epicardial adipose tissue with progression of coronary artery calcification is more pronounced in the early phase of atherosclerosis: results from the Heinz Nixdorf recall study.
    Mahabadi AA; Lehmann N; Kälsch H; Robens T; Bauer M; Dykun I; Budde T; Moebus S; Jöckel KH; Erbel R; Möhlenkamp S
    JACC Cardiovasc Imaging; 2014 Sep; 7(9):909-16. PubMed ID: 25190138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Signs of subclinical coronary atherosclerosis in relation to risk factor distribution in the Multi-Ethnic Study of Atherosclerosis (MESA) and the Heinz Nixdorf Recall Study (HNR).
    Erbel R; Delaney JA; Lehmann N; McClelland RL; Möhlenkamp S; Kronmal RA; Schmermund A; Moebus S; Dragano N; Stang A; Jöckel KH; Budoff MJ; ;
    Eur Heart J; 2008 Nov; 29(22):2782-91. PubMed ID: 18845666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic variations in G-protein signal pathways influence progression of coronary artery calcification: Results from the Heinz Nixdorf Recall study.
    Klenke S; Lehmann N; Erbel R; Jöckel KH; Siffert W; Frey UH; Peters J
    Atherosclerosis; 2020 Oct; 310():102-108. PubMed ID: 32680596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sleep characteristics and progression of coronary artery calcification: Results from the Heinz Nixdorf Recall cohort study.
    Kowall B; Lehmann N; Mahabadi AA; Lehnich AT; Moebus S; Budde T; Seibel R; Grönemeyer D; Erbel R; Jöckel KH; Stang A
    Atherosclerosis; 2018 Apr; 271():45-52. PubMed ID: 29459265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of subclinical coronary atherosclerosis and risk factors in unselected populations in Germany and US-America.
    Schmermund A; Lehmann N; Bielak LF; Yu P; Sheedy PF; Cassidy-Bushrow AE; Turner ST; Moebus S; Möhlenkamp S; Stang A; Mann K; Jöckel KH; Erbel R; Peyser PA
    Atherosclerosis; 2007 Nov; 195(1):e207-16. PubMed ID: 17532322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of progressive thoracic aortic calcification with future cardiovascular events and all-cause mortality: ability to improve risk prediction? Results of the Heinz Nixdorf Recall (HNR) study.
    Kälsch H; Mahabadi AA; Moebus S; Reinsch N; Budde T; Hoffmann B; Stang A; Jöckel KH; Erbel R; Lehmann N
    Eur Heart J Cardiovasc Imaging; 2019 Jun; 20(6):709-717. PubMed ID: 30508179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beyond Framingham risk factors and coronary calcification: does aortic valve calcification improve risk prediction? The Heinz Nixdorf Recall Study.
    Kälsch H; Lehmann N; Mahabadi AA; Bauer M; Kara K; Hüppe P; Moebus S; Möhlenkamp S; Dragano N; Schmermund A; Stang A; Jöckel KH; Erbel R;
    Heart; 2014 Jun; 100(12):930-7. PubMed ID: 24501258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Noncoronary Measures Enhance the Predictive Value of Cardiac CT Above Traditional Risk Factors and CAC Score in the General Population.
    Mahabadi AA; Lehmann N; Möhlenkamp S; Pundt N; Dykun I; Roggenbuck U; Moebus S; Jöckel KH; Erbel R; Kälsch H;
    JACC Cardiovasc Imaging; 2016 Oct; 9(10):1177-1185. PubMed ID: 27450878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Assessment of the natural history of coronary artery calcification and identification of its determinants. Rationale of the 2nd part of the Heinz Nixdorf Recall Study].
    Möhlenkamp S; Moebus S; Schmermund A; Lehmann N; Hoffmann B; Neumann T; Stang A; Dragano N; Kerkhoff G; Naber C; Kälsch H; Beck EM; Bröcker-Preuss M; Kröger K; Budde T; Siegrist J; Mann K; Jöckel KH; Erbel R;
    Herz; 2007 Mar; 32(2):108-20. PubMed ID: 17401753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coronary artery calcification outperforms thoracic aortic calcification for the prediction of myocardial infarction and all-cause mortality: the Heinz Nixdorf Recall Study.
    Kälsch H; Lehmann N; Berg MH; Mahabadi AA; Mergen P; Möhlenkamp S; Bauer M; Kara K; Dragano N; Hoffmann B; Moebus S; Schmermund A; Stang A; Jöckel KH; Erbel R
    Eur J Prev Cardiol; 2014 Sep; 21(9):1163-70. PubMed ID: 23467675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Left ventricle size quantification using non-contrast-enhanced cardiac computed tomography--association with cardiovascular risk factors and coronary artery calcium score in the general population: The Heinz Nixdorf Recall Study.
    Dykun I; Mahabadi AA; Lehmann N; Bauer M; Moebus S; Jöckel KH; Möhlenkamp S; Erbel R; Kälsch H
    Acta Radiol; 2015 Aug; 56(8):933-42. PubMed ID: 25033994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of smoking and other traditional risk factors on the onset of coronary artery calcification: results of the Heinz Nixdorf recall study.
    Lehmann N; Möhlenkamp S; Mahabadi AA; Schmermund A; Roggenbuck U; Seibel R; Grönemeyer D; Budde T; Dragano N; Stang A; Mann K; Moebus S; Erbel R; Jöckel KH
    Atherosclerosis; 2014 Feb; 232(2):339-45. PubMed ID: 24468147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progression of coronary artery calcification is stronger in poorly than in well controlled diabetes: Results from the Heinz Nixdorf Recall Study.
    Kowall B; Lehmann N; Mahabadi AA; Moebus S; Budde T; Seibel R; Grönemeyer D; Erbel R; Jöckel KH; Stang A
    J Diabetes Complications; 2017 Jan; 31(1):234-240. PubMed ID: 27665253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Associations of metabolically healthy obesity with prevalence and progression of coronary artery calcification: Results from the Heinz Nixdorf Recall Cohort Study.
    Kowall B; Lehmann N; Mahabadi AA; Moebus S; Erbel R; Jöckel KH; Stang A
    Nutr Metab Cardiovasc Dis; 2019 Mar; 29(3):228-235. PubMed ID: 30648599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gender-specific association of coronary artery calcium and lipoprotein parameters: the Heinz Nixdorf Recall Study.
    Erbel R; Lehmann N; Churzidse S; Möhlenkamp S; Moebus S; Mahabadi AA; Schmermund A; Stang A; Dragano N; Grönemeyer D; Seibel R; Kälsch H; Bauer M; Bröcker-Preuss M; Mann K; Jöckel KH;
    Atherosclerosis; 2013 Aug; 229(2):531-40. PubMed ID: 23701995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.